-
Recent CDC advisory panel declined to recommend COVID-19 vaccines for any age group this fall, leaving vaccination decisions to individuals and healthcare providers. The move follows FDA restrictions limiting vaccine access and reflects shifting attitudes amid ongoing debates about vaccine safety and policy. The decision impacts vaccine coverage and public trust.
-
The CDC advisory committee is set to reconsider the recommendation for universal hepatitis B vaccination at birth, amid political pressure and vaccine skepticism. The decision could impact childhood immunization rates and public health efforts to prevent lifelong liver disease.
-
U.S. health officials, under the influence of Secretary Robert F. Kennedy Jr., have reversed decades of vaccination policy by ending universal hepatitis B vaccination for newborns. The move, driven by a panel with controversial appointees, faces widespread criticism from medical groups and public health experts, raising concerns over increased hepatitis B risks.